Download PDF
Journal Club AINS 2014; 3(2): 108-115
DOI: 10.1055/s-0034-1382814
Leitlinien in der Praxis
© Georg Thieme Verlag Stuttgart · New York

Update Sepsis 2013 – Die wichtigsten Neuerungen aus den Leitlinien der Surviving Sepsis Campaign (SSC)

Katja Weismüller
,
Michael Henrich
,
Herwig Gerlach
,
Markus A Weigand
Further Information

Publication History

Publication Date:
23 July 2014 (online)

Also available at
    Permissions and Reprints

Die Sepsis ist eines der häufigsten und wichtigsten intensivmedizinischen Krankheitsbilder. Ihre konsequente Diagnostik und Therapie ist in erster Linie für den Patienten von entscheidender Bedeutung, aber auch folgenreich für die Krankenhausökonomie. Die Leitlinien der SSC sollen eine Behandlung nach den Maßstäben aktueller klinischer Untersuchungen harmonisieren und damit für den Kliniker erleichtern. Durch die Fülle neuer Erkenntnisse ist es notwendig, vorhandene Leitlinien in regelmäßigen Abständen zu aktualisieren und zu erweitern, sowie lange bestehende Diskussionen weiterzuführen. Hierdurch soll der ständigen Weiterentwicklung medizinischen Wissens Rechnung getragen werden.

 

  • Literatur

  • 1 Levy M, Fink M, Marshall J et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definition conference. Crit Care Med 2003; 31: 1250-1256
    CrossrefGoogle Scholar
  • 2 Dellinger R, Levy M, Rhodes A et al. The Surviving Sepsis Campaign Committee. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-225
    CrossrefPubMedGoogle Scholar
  • 3 Marik P, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134: 172-178
    CrossrefGoogle Scholar
  • 4 Lanspa M, Brown S, Hirshberg E et al. Central venous pressure and shock index predict lack of hemodynamic response to volume expansion in septic shock: A prospective, observational study. J Crit Care 2012; 27: 609-615
    CrossrefGoogle Scholar
  • 5 Jansen T, van Bommel J, Schoonderbeek F et al. LACTATE study group. Early lactate-guided therapy in intensive care unit patients: A multicenter, openlabel, randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 752-761
    CrossrefGoogle Scholar
  • 6 Jones A, Shapiro N, Trzeciak S et al. Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010; 303: 739-746
    CrossrefGoogle Scholar
  • 7 Levy M, Dellinger R, Townsend S et al. The surviving sepsis campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38: 367-374
    CrossrefGoogle Scholar
  • 8 Weinstein M, Reller L, Murphy J, Lichtenstein K. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5: 35-53
    CrossrefGoogle Scholar
  • 9 Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36: 105-109
    Google Scholar
  • 10 Giamarellos-Bourboulis E, Giannopoulou P, Grecka P et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?. J Crit Care 2004; 19: 152-157
    CrossrefGoogle Scholar
  • 11 Tang B, Eslick G, Craig J, McLean A. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 210-217
    CrossrefGoogle Scholar
  • 12 Uzzan B, R RC P PN Cucherat M, Perret G. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003
    CrossrefGoogle Scholar
  • 13 Wacker C, Prkno A, Brunkhorst F, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 426-435
    CrossrefPubMedGoogle Scholar
  • 14 Alam F, Mustafa A, Khan Z. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103-103
    CrossrefGoogle Scholar
  • 15 Oliveri S, Trovato L, Betta P et al. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008; 14: 391-393
    CrossrefGoogle Scholar
  • 16 Sendid B, Poirot J, Tabouret M et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002; 51: 433-442
    Google Scholar
  • 17 Sendid B, Jouault T, Coudriau R et al. Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol 2004; 42: 164-171
    CrossrefGoogle Scholar
  • 18 Sendid B, Dotan N, Nseir S et al. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 2008; 15: 1868-1877
    CrossrefGoogle Scholar
  • 19 Yera H, Sendid B, Francois N et al. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 2001; 20: 864-870
    CrossrefGoogle Scholar
  • 20 Kumar A, Roberts D, Wood K et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596
    CrossrefPubMedGoogle Scholar
  • 21 Ferrer R, Artigas A, Suarez D et al. Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180: 861-866
    CrossrefGoogle Scholar
  • 22 Barie P, Hydo L, Shou J et al. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect 2005; 6: 41-54
    CrossrefGoogle Scholar
  • 23 Castellanos-Ortega A, Suberviola B, García-Astudillo L et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med 2010; 38: 1036-1043
    CrossrefGoogle Scholar
  • 24 Puskarich M, S ST Shapiro N, Arnold R. et al. Emergency Medicine Shock Research Network (EMSHOCKNET). Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011; 39: 2066-2071
    CrossrefGoogle Scholar
  • 25 Solh AE, Akinnusi M, Alsawalha L, Pineda L. Outcome of septic shock in older adults after implementation of the sepsis „bundle“. J Am Geriat Soc 2008; 56: 272-278
    CrossrefGoogle Scholar
  • 26 Gurnani P, Patel G, Crank C, Vais D, Lateef O, Akimov S, Balk R, Simon D. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Therap 2010; 32: 1285-1293
    CrossrefGoogle Scholar
  • 27 Barochia A, Cui X, Vitberg D, Suffredini A, O'Grady N, Banks S, Minneci P, Kern S, Danner R, Natanson C, Eichacker P. Bundled care for septic shock: An analysis of clinical trials. Crit Care Med 2010; 38: 668-678
    CrossrefGoogle Scholar
  • 28 Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik S. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386
    CrossrefPubMedGoogle Scholar
  • 29 Ibrahim E, Sherman G, Ward S, Fraser V, Kollef M. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155
    CrossrefPubMedGoogle Scholar
  • 30 Heyland D, Johnson A, Reynolds S, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 2011; 39: 1793-1799
    Google Scholar
  • 31 Jensen J, Hein L, Lundgren B, Bestle M, Mohr T, Andersen M, Thornberg K, Løken J, Steensen M, Fox Z, Tousi H, Søe-Jensen P, Lauritsen A, Strange D, Petersen P, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen K, Drenck N, Ostergaard C, Kjær J, Grarup J, Lundgren J. Procalcitonin And Survival Study (PASS) Group. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011; 39: 2048-2058
    CrossrefGoogle Scholar